Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)
June 1996
There's a lot of excitement about Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS).
Avonex is a beta-interferon...but it's chemically different from Betaseron (interferon beta-1b). That might explain some of the differences in their effects.
Both Avonex and Betaseron reduce the frequency of attacks in patients with the relapsing-remitting form of MS.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote